10/04/2021  h. 13:33   
   Overview   |  
Commission proposes to purchase up to 300 million additional doses of BioNTech-Pfizer vaccine

11/01/2021 | Economy |  Daily News 08 / 01 / 2021

Source: European Commission Spokesperson's Service  



The European Commission today proposed to the EU Member States to purchase an additional 200 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses. This would enable the EU to purchase up to 600 million doses of this vaccine, which is already being used across the EU. The additional doses will be delivered starting in the second quarter of 2021. The EU has acquired a broad portfolio of vaccines with different technologies. It has secured up to 2.3 billion doses from the most promising vaccine candidates for Europe and its neighbourhood. In addition to the BioNTech-Pfizer vaccine, a second vaccine, produced by Moderna, was authorised on 6 January 2021. Other vaccines are expected to be approved soon. This vaccine portfolio would enable the EU not only to cover the needs of its whole population, but also to supply vaccines to neighbouring countries. More information is available in the press release and on the dedicated website. Watch the press conference with President von der Leyen here, and read her remarks here.


Share: 
Wikio OkNotizie Del.icio.us! Google! Facebook! Technorati! Upnews.it


Last news - All topics
Economy
  Today Marca Amica, the food and wine and agri-tourism guide of Terranostra and Coldiretti Treviso, was presented
2 April 2021
Courses & Conferences
  Digitale kompetenzen wie sich die Rolle und die Didaktik von Trainer und Lehrkräften ändern
24 March 2021
Sport
  Cortina 2021. The Men's Giant will be opened by the Swiss Marco Odermatt
19 February 2021
Events
  Friday, April 9 show Glances: saying, doing, working
7 April 2021
Et cetera
  Shrewsbury’s Early offers to world-class universities
29 March 2021